Table 1 Postoperative treatment and the prognosis of patients who underwent surgery for gastric IM from esophageal cancer
Author | Year | Age (years)/sex | Operation | Postoperative treatment | Survival time (months) |
|---|---|---|---|---|---|
Yoshizumi et al. | 1985 | 65/M | E+TG | None | ND |
Yoshida et al. | 1989 | 64/M | EÂ +Â PG | Chemotherapy | 3 |
Takano et al. | 1989 | 61/M | EÂ +Â TG | None | ND |
Tajika et al. | 1999 | 67/M | EÂ +Â LR | None | ND |
Uehara et al. | 2008 | 67/M | EÂ +Â TG | None | 11 |
Nakazawa et al. | 2014 | 59/M | E + PG (+ α) | DCF | 8 |
Okumura et al. | 2015 | 68/M | EÂ +Â TG | None | 14 |
Hosoda et al. | 2018 | 73/M | TG | None | 3 |